BML-284 HCL

CAS No. 2095432-75-8

BML-284 HCL( Wnt agonist 1 HCL )

Catalog No. M22979 CAS No. 2095432-75-8

BML-284 HCL is a potent, selective Wnt canonical signaling activator and tubulin polymerization inhibitor.BML-284 HCL does not inhibit the activity of GSK-3β, and may be a useful tool in the study of physiological processes that involve the Wnt pathway.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 56 In Stock
10MG 73 In Stock
25MG 138 In Stock
50MG 253 In Stock
100MG 438 In Stock
200MG 615 In Stock
500MG 963 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BML-284 HCL
  • Note
    Research use only, not for human use.
  • Brief Description
    BML-284 HCL is a potent, selective Wnt canonical signaling activator and tubulin polymerization inhibitor.BML-284 HCL does not inhibit the activity of GSK-3β, and may be a useful tool in the study of physiological processes that involve the Wnt pathway.
  • Description
    BML-284 HCL is a potent, selective Wnt canonical signaling activator and tubulin polymerization inhibitor.BML-284 HCL does not inhibit the activity of GSK-3β, and may be a useful tool in the study of physiological processes that involve the Wnt pathway. In a Xenopus model, Wnt agonist 1 (10 μM) mimics the effects of Wnt at the whole-organism level, and affects Xenopus embryonic head specification.
  • In Vitro
    BML-284 (10 μM; 24 hours) induces the expression of β-catenin significantly when compared with the NC group. It also partially reverses the effects induced by pizotifen on E-cadherin and N-cadherin expression in MNK45 and AGS cells compared with the pizotifen-treated group.BML-284 (10 μM; 24 hours) significantly increases the migration and invasion of both MNK45 and AGS cells and partially restores the migratory and invasive abilities of cells inhibited by pizotifen. Western Blot Analysis Cell Line:Human gastric cancer cell lines MNK45 and AGS Concentration:10 μM Incubation Time:24 hours Result:Induced β-catenin expression and reserved E-cadherin and N-cadherin expression in MNK45 and AGS cells.
  • In Vivo
    BML-284 hydrochloride (10 ng) combines with Pyrimethanil (4 mg/L) could partially rescue the malformed phenotype and cardiac defects induced by Pyrimethanil in Tg (myl7:EGFP) transgenic embryos at 5.5 hpf are transferred into plates with 20 embryos.
  • Synonyms
    Wnt agonist 1 HCL
  • Pathway
    Wnt/Notch/Hedgehog
  • Target
    Wnt/beta/catenin
  • Recptor
    Wnt
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2095432-75-8
  • Formula Weight
    386.84
  • Molecular Formula
    C19H19ClN4O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    NC1=NC(C2=CC=CC(OC)=C2)=CC(NCC3=CC=C(OCO4)C4=C3)=N1.[H]Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Angew Chem Int Ed Engl. 2005, 44(13), 1987-1990.
molnova catalog
related products
  • Adavivint

    Adavivint (SM-04690, SM 04690, SM04690) is a novel small molecule Wnt pathway inhibitor with EC50 of 3 nM in vitro.

  • ZW4864 free base

    ZW4864 (free base) is an orally active and selective β-catenin/B-Cell lymphoma 9 protein-protein interaction (β-catenin/BCL9 PPI) inhibitor, with a K_i value of 0.76 μM and an IC_50 value of 0.87 μM .

  • Wnt/β-catenin agonis...

    Wnt/β-catenin agonist 2 activates Wnt/β-catenin signaling and is an effective Wnt agonist.